| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $-0.51 (Beat by $0.02) |
| EPS GAAP Actual | $-0.51 (Beat by $0.02) |
| Revenue Actual | $0.399B |
| Revenue Surprise | Beat by $399M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.37911B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.6 | 30.6 | 0.58845 | 0.61155 | 1 |
| Dec 2027 | 3.26 | 5.63 | 3.26 | 3.26 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -3.3 | -3.46 | 0.399B | 1.43% | 6M |
| FQ2 2025 (Jun 2025) | 0.17 | -0.18 | 0.3918B | -49.67% | 0.8M |
| FQ1 2025 (Mar 2025) | -0.38 | -0.55 | 0.3782B | -31.2% | -8.8M |
| FQ4 2024 (Dec 2024) | 11.91 | 10.84 | 0.3871B | -32.5% | -256.9M |
| FQ3 2024 (Sep 2024) | 0.35 | 0.43 | 0.3933B | -32.19% | -103.7M |
| FQ2 2024 (Jun 2024) | -1.55 | -1.55 | 0.5864B | 100% | 586.4M |
| FQ1 2024 (Mar 2024) | 1.04 | 1.04 | 0.4962B | 100% | 496.2M |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 0.5129B | 100% | 512.9M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.37911B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.45 | -- | 0.45 | 0.45 | 1 |
| FQ3 2027 (Sep 2027) | 0.45 | -- | 0.45 | 0.45 | 1 |
| FQ2 2027 (Jun 2027) | 0.38 | -- | 0.38 | 0.38 | 1 |
| FQ1 2027 (Mar 2027) | 0.09 | -- | 0.09 | 0.09 | 1 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.4B | -- | 0.4B | 0.4B | 1 |
| FQ3 2027 (Sep 2027) | 0.4B | -- | 0.4B | 0.4B | 1 |
| FQ2 2027 (Jun 2027) | 0.4B | -- | 0.4B | 0.4B | 1 |
| FQ1 2027 (Mar 2027) | 0.4B | -- | 0.4B | 0.4B | 1 |
| FQ4 2026 (Dec 2026) | 0.4B | -- | 0.4B | 0.4B | 1 |
| FQ3 2026 (Sep 2026) | 0.39B | -1.99 | 0.39B | 0.39B | 1 |
| FQ2 2026 (Jun 2026) | 0.39B | -0.8 | 0.39B | 0.39B | 1 |
| FQ1 2026 (Mar 2026) | 0.38B | 0.24 | 0.38B | 0.38B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16 | -3.3 | -3.46 | 104.85% |
| FQ2 2025 (Jun 2025) | 0.35 | 0.17 | -0.18 | -105.88% |
| FQ1 2025 (Mar 2025) | 0.17 | -0.38 | -0.55 | 144.74% |
| FQ4 2024 (Dec 2024) | 1.07 | 11.91 | 10.84 | 91.02% |
| FQ3 2024 (Sep 2024) | -0.08 | 0.35 | 0.43 | 122.86% |
| FQ2 2024 (Jun 2024) | -1.55 | -1.55 | 100% | |
| FQ1 2024 (Mar 2024) | 1.04 | 1.04 | 100% | |
| FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.39B | $0.4B | $6M | 1.5% |
| FQ2 2025 (Jun 2025) | $0.39B | $0.39B | $0.8M | 0.2% |
| FQ1 2025 (Mar 2025) | $0.39B | $0.38B | $-8.8M | -2.33% |
| FQ4 2024 (Dec 2024) | $0.64B | $0.39B | $-256.9M | -66.37% |
| FQ3 2024 (Sep 2024) | $0.5B | $0.39B | $-103.7M | -26.37% |
| FQ2 2024 (Jun 2024) | $0B | $0.59B | $586.4M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.5B | $496.2M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.51B | $512.9M | 100% |